Kemp JP - Search Results

1

Pharmacokinetics of a novel 5-lipoxygenase inhibitor (ABT-761) in pediatric patients with asthma.

Wong SL, Kearns GL, Kemp JP, Drajesk J, Chang M, Locke CS, Dube LM, Awni WM. Wong SL, et al. Among authors: kemp jp. Eur J Clin Pharmacol. 1998 Nov-Dec;54(9-10):715-9. doi: 10.1007/s002280050540. Eur J Clin Pharmacol. 1998. PMID: 9923573 Clinical Trial.

2

Safety and clinical efficacy of zileuton in patients with chronic asthma.

Lazarus SC, Lee T, Kemp JP, Wenzel S, Dubé LM, Ochs RF, Carpentier PJ, Lancaster JF. Lazarus SC, et al. Among authors: kemp jp. Am J Manag Care. 1998 Jun;4(6):841-8. Am J Manag Care. 1998. PMID: 10181070 Free article. Clinical Trial.

3

Efficacy of zileuton controlled-release tablets administered twice daily in the treatment of moderate persistent asthma: a 3-month randomized controlled study.

Nelson H, Kemp J, Berger W, Corren J, Casale T, Dube L, Walton-Bowen K, LaVallee N, Stepanians M. Nelson H, et al. Ann Allergy Asthma Immunol. 2007 Aug;99(2):178-84. doi: 10.1016/S1081-1206(10)60642-4. Ann Allergy Asthma Immunol. 2007. PMID: 17718106 Clinical Trial.

4

Bronsky EA, Kemp JP, Zhang J, Guerreiro D, Reiss TF. Bronsky EA, et al. Among authors: kemp jp. Clin Pharmacol Ther. 1997 Nov;62(5):556-61. doi: 10.1016/S0009-9236(97)90051-5. Clin Pharmacol Ther. 1997. PMID: 9390112 Clinical Trial.

5

The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma.

Israel E, Rubin P, Kemp JP, Grossman J, Pierson W, Siegel SC, Tinkelman D, Murray JJ, Busse W, Segal AT, Fish J, Kaiser HB, Ledford D, Wenzel S, Rosenthal R, Cohn J, Lanni C, Pearlman H, Karahalios P, Drazen JM. Israel E, et al. Among authors: kemp jp. Ann Intern Med. 1993 Dec 1;119(11):1059-66. doi: 10.7326/0003-4819-119-11-199312010-00001. Ann Intern Med. 1993. PMID: 8239223 Clinical Trial.

6

Role of leukotriene receptor antagonists in pediatric asthma.

Kemp JP. Kemp JP. Pediatr Pulmonol. 2000 Aug;30(2):177-82. doi: 10.1002/1099-0496(200008)30:2<177::aid-ppul16>3.0.co;2-e. Pediatr Pulmonol. 2000. PMID: 10922143

7

Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group.

Edelman JM, Turpin JA, Bronsky EA, Grossman J, Kemp JP, Ghannam AF, DeLucca PT, Gormley GJ, Pearlman DS. Edelman JM, et al. Among authors: kemp jp. Ann Intern Med. 2000 Jan 18;132(2):97-104. doi: 10.7326/0003-4819-132-2-200001180-00002. Ann Intern Med. 2000. PMID: 10644288 Clinical Trial.

8

Advances in the management of pediatric asthma: a review of recent FDA drug approvals and label updates.

Kemp JP. Kemp JP. J Asthma. 2005 Oct;42(8):615-22. doi: 10.1080/02770900500214775. J Asthma. 2005. PMID: 16266950 Review.

9

Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.

Leff JA, Busse WW, Pearlman D, Bronsky EA, Kemp J, Hendeles L, Dockhorn R, Kundu S, Zhang J, Seidenberg BC, Reiss TF. Leff JA, et al. N Engl J Med. 1998 Jul 16;339(3):147-52. doi: 10.1056/NEJM199807163390302. N Engl J Med. 1998. PMID: 9664090 Free article. Clinical Trial.

10

Salmeterol powder compared with albuterol aerosol as maintenance therapy for asthma in adolescent and adult patients.

Kemp J, Wolfe J, Grady J, LaForce C, Stahl E, Arledge T, Liddle R. Kemp J, et al. Clin Ther. 1998 Mar-Apr;20(2):270-82. doi: 10.1016/s0149-2918(98)80090-8. Clin Ther. 1998. PMID: 9589818 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

215 results

Search Page

Filters